Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours

A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 206 participants.

Also called NCT01692379

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 206 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01692379
Other papers using this trial's data
  • Association Between Time to Reperfusion and Outcome Is Primarily Driven by the Time From Imaging to Reperfusion Stroke, 2016-04 DOI, PubMed 26956258
  • Endovascular treatment improves cognition after stroke: A secondary analysis of REVASCAT trial Neurology, 2017-01-17 DOI, PubMed 27940648, PMC5272792 Not in the PMC Open Access subset.
  • Phone and Video-Based Modalities of Central Blinded Adjudication of Modified Rankin Scores in an Endovascular Stroke Trial Stroke, 2015-12 DOI, PubMed 26542697
  • Posttreatment Infarct Volumes when Compared with 24-Hour and 90-Day Clinical Outcomes: Insights from the REVASCAT Randomized Controlled Trial AJNR. American journal of neuroradiology, 2018-01 DOI, PubMed 29170266, PMC7410691 Not in the PMC Open Access subset.
  • Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial The Lancet. Neurology, 2017-05 DOI, PubMed 28318984
  • Thrombectomy within 8 hours after symptom onset in ischemic stroke The New England journal of medicine, 2015-06-11 DOI, PubMed 25882510
  • Vessel Patency at 24 Hours and Its Relationship With Clinical Outcomes and Infarct Volume in REVASCAT Trial (Randomized Trial of Revascularization With Solitaire FR Device Versus Best Medical Therapy in the Treatment of Acute Stroke Due to Anterior Circulation Large Vessel Occlusion Presenting Within Eight Hours of Symptom Onset) Stroke, 2017-04 DOI, PubMed 28292867

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT01692379. Randomized; single masking; primary purpose treatment. Start 2012-11 (registry gives no type); primary completion 2015-03 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Endovascular Revascularization With Solitaire Device Versus Best Medical Therapy in Anterior Circulation Stroke Within 8 Hours
Acronym
REVASCAT
Condition
Acute Stroke
Intervention (Device)
Solitaire FR device
Intervention (Other)
Medical treatment
Lead sponsor
Fundacio Ictus Malaltia Vascular (class: other)
Collaborator
Medtronic - MITG (class: industry)

Record details

Record id
cardio:ct-nct01692379
Content hash
d1b43c624f197fc9d41e4780265a48ecb86bd09a03ad6ac0ae0d875ef7cf7cd9